Heart Medication for Parkinson’s

RESEARCH ScienceDaily (Jan. 23, 2010) — UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease.

In the first large-scale population-based study of its kind, Dr. Beate Ritz, professor of epidemiology at the UCLA School of Public Health, in collaboration with researchers from the Danish Cancer Society, found that a specific sub-class of dihydropyridine cardiovascular medications was associated with a 26 to 30 percent decrease in the risk of Parkinson's. The findings appear in an upcoming print edition of the journal Annals of Neurology and are currently available online.

Tags: cardiology, clinical trial study, drugs, medicine, mental, neurology, pharmaceutical, pharmacology, research

Reference

Read complete article at ScienceDaily.com.